Trial intelligence / Profile preview

Intramuscular versus subcutaneous tetanus-diphtheria vaccination in anticoagulated patients

ISRCTN69942081Phase 4Completed

Sponsor
Consellería de Sanidade
Start
Jan 2009
Modality
Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tetanus and diphtheria toxoids adsorbed in Tetanus and diphtheria (2 arms), sponsored by Consellería de Sanidade. Primary endpoint: Increase in anti-tetanus antibody titer. Started Jan 2009; status: completed.

02

Drugs

tetanus and diphtheria toxoids adsorbed
03

Conditions

Tetanusdiphtheria

Beyond the preview

Go deeper on ISRCTN69942081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN69942081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call